Yangang Wang

Qingdao University - Affiliated Hospital

Qingdao, Shandong 266000

China

SCHOLARLY PAPERS

2

DOWNLOADS

59

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Efficacy and Safety of the Peroxisome Proliferator-Activated Receptor Pan-Agonist Chiglitazar in Patients with Type 2 Diabetes (CMAP): A 24 Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase 3 Superiority Trial

Number of pages: 100 Posted: 21 Aug 2019
Peking University - Department of Endocrinology and Metabolism, Southern Medical University - Chenzhou No.1 People's Hospital, Tangshan Gongren Hospital, Xuzhou Medical University, Harrison International Peace Hospital, Qingdao University - Affiliated Hospital, China Three Gorges University (CTGU) - College of Medical Science, Jilin University (JLU) - Second Hospital, Jiangsu Province Hospital, China Meitan General Hospital, Chongqing University, Chongqing Medical University - Department of Endocrinology, Hebei Medical University, Tianjin Medical University - General Hospital, Government of the People's Republic of China - 306th Hospital, Baogang Hospital of Inner Mongolia, Cangzhou Central Hospital, Fudan University - Zhongshan Hospital, Sichuan University, Government of the People's Republic of China - Fourth Military Medical University, Shanghai Jiao Tong University (SJTU) - Xinhua Hospital, The Second Xiangya Hospital of Central South University - Key Laboratory of Diabetes Immunology, Peking University, Central South University - Second Xiangya Hospital, Xiamen University - First Affiliated Hospital, School of Economics and Management - Zhongnan Hospital, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd and Shanghai Jiao Tong University (SJTU) - Department of Endocrinology and Metabolism
Downloads 40 (627,015)

Abstract:

Loading...

2.

Insulin Delivery with a Needle-Free Insulin Injector Versus a Conventional Insulin Pen in Chinese Patients with Type 2 Diabetes Mellitus: A 16-Week, Multicenter, Randomized Clinical Trial (the FREE Study)

Number of pages: 30 Posted: 21 Feb 2020
Peking University - Department of Endocrinology and Metabolism, Peking University - Department of Endocrinology and Metabolism, Tianjin Medical University - Metabolic Disease Hospital, Qingdao University - Affiliated Hospital, Tianjin Medical University - Department of Endocrinology and Metabolism, Sichuan University - West China Hospital, Southeast University - Department of Endocrinology, Government of the People's Republic of China - Fuzhou General Hospital, Jilin University (JLU) - Department of Endocrinology and Metabolism, Beijing Hospital - National Center of Gerontology, Department of Endocrinology and China Medical University - Department of Endocrinology and Metabolism
Downloads 19 (776,650)

Abstract:

Loading...

Diabetes mellitus; Efficacy; HbA1c; Insulin; Needle-free injector; Safety; Type 2